Section 16(a) of the Securities Exchange Act of 1934, requires the Fund’s directors and executive officers to file reports of ownership and changes in ownership of their equity securities of the Fund with the Securities and Exchange Commission and to furnish the Fund with copies of such reports. To the best of the Fund’s knowledge, all of the filings by the Fund’s directors and executive officers were made on a timely basis during the 2023 fiscal year, except for Ms. Hu. A Statement of Changes of Beneficial Ownership of Securities on Form 4 for Ms. Hu was not timely filed during the 2023 fiscal year due to an inadvertent administrative error. The Form 4 for Ms. Hu, which was filed on September 29, 2023, related to a purchase of Fund shares executed on September 26, 2023. For timely filing, the Form 4 should have been filed one day earlier on September 28, 2023. In addition, the Initial Statements of Beneficial Ownership of Securities on Form 3 for Ms. Hu and Ms. Noriega-Lum were not timely filed for the 2022 fiscal year due to an inadvertent administrative error. Ms. Hu was elected as a Director of the Fund on May 3, 2022 and Ms. Noriega-Lum was appointed as President of the Fund effective January 1, 2022. To the best of the Fund’s knowledge, all of the filings by the Fund’s other directors and executive officers were made on a timely basis during the 2022 fiscal year.

 

  taitweller.com

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors

The China Fund, Inc.

Boston, Massachusetts

 

In planning and performing our audit of the financial statements of The China Fund, Inc. (the “Fund”) as of and for the year ended October 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered its internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

 

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Such internal control includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

 

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control deficiency, or combination of control deficiencies, that adversely affects the company’s ability to initiate, authorize, record, process or report financial data reliably in accordance with accounting principles generally accepted in the United States of America such that there is more than a remote likelihood that a misstatement of the company’s annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

 

 

 

 

To the Shareholders and Board of Directors

The China Fund, Inc.

Page Two

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be significant deficiencies or material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of October 31, 2023.

 

This report is intended solely for the information and use of management, Shareholders and Board of Directors of the Fund and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties.

 

 

TAIT, WELLER & BAKER LLP

Philadelphia, Pennsylvania

December 22, 2023


China (NYSE:CHN)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse China
China (NYSE:CHN)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse China